SBD.4 stimulates regenerative processes in vitro, and wound healing in genetically diabetic mice and in human skin/severe-combined immunodeficiency mouse chimera.
SBD.4 stimulates regenerative processes in vitro, and wound healing in genetically diabetic mice and in human skin/severe-combined immunodeficiency mouse chimera.
复制标题
SBD.4 可刺激遗传性糖尿病小鼠和人类皮肤/严重联合免疫缺陷小鼠嵌合体的体外再生过程和伤口愈合。
DOI:
10.1111/j.1743-6109.2006.00166.x
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
Bojanowski,Krzysztof
中科院分区:
文献类型:
--
作者:
Zhao,Hui;Mortezaei,Reza;Wang,Yanrong;Sheng,Xinsheng;Aria,Fariba;Bojanowski,Krzysztof
In search of novel angiostimulators, we performed a high‐throughput screening of medicinal plants beneficial for blood circulation. From the panel of positive hits,Angelica sinensiswas selected for further investigation. Purified down to a low‐molecular‐weight fraction and characterized by high‐performance liquid chromatography–mass spectrometry, the material, named SBD.4A, revealed a particularly strong wound healing activity in the diabetic mouse wound‐healing model, and in the human/severe combined immunodeficiency mouse chimera wound‐healing model. In both models, SBD.4A compared favorably with the Food and Drug Administration‐approved wound‐healing drug becaplermin, suggesting that this botanical product could be a valuable treatment for difficult‐to‐heal wounds. Further high‐performance liquid chromatography fractionation of SBD.4A yielded a hydrophilic fraction, which strongly stimulated endothelial cell proliferation, tridimensional endothelial cell network formation, as well as the proliferation of human dermal fibroblasts and type I collagen secretion. Because angiogenesis and fibroblast proliferation are essential for wound healing, we propose that this liquid chromatography–mass spectrometry‐defined hydrophilic fraction is at least partially responsible for the wound‐healing activity of SBD.4A.